UNS
Click for more information
0.00% 0.5¢ unilife corporation

Amgen transcript line

  1. railroadman
    1,266 Posts.
    clock Created with Sketch.
    03/02/17
    23:57
    Post #: 22365938
    Taken from Amgen's earning call transcript. Novel Delivery Systems????????????? RRM

    We continue to invest strategically in Enbrel, including pursuit of new indications and "novel delivery"" systems to enhance the value it brings to patients and providers. Given its long period of patent protection, Enbrel will continue to generate significant cash flows for many years to come.
    UNS Price at posting: 4.9¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Reporting Wrap 28 Aug: Tabcorp slammed, Woolworths' soft gains; Nine; Lynas & APA Group
right-arrow Created with Sketch.
HYT Twiggy Forrest to acquire 40% of native hydrogen explorer – not long after putting Fortescue Future Industries to sleep
right-arrow Created with Sketch.
HVN Consumers cautious according to Harvey Norman, as profit slumps 35% in FY24
right-arrow Created with Sketch.
EBR EBR reaches review milestone for wireless cardiac pacing device
right-arrow Created with Sketch.
NEWS Inflation cools in the 12 months to July, on-target reading of 3.5%
right-arrow Created with Sketch.
FMG FMG reports third highest earnings in history on strong iron ore sales
right-arrow Created with Sketch.
watchlist Created with Sketch. Add UNS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.